期刊
ADVANCED HEALTHCARE MATERIALS
卷 1, 期 5, 页码 567-572出版社
WILEY
DOI: 10.1002/adhm.201200116
关键词
-
资金
- Beckman Institute of the University of Illinois
- US National Science Foundation [CMMI 0749028, DMR-0117792]
- National Institute of Health (NIH) [1DP2OD007246, 1R21CA152627]
Spatiotemporal control over the delivery of therapeutic agents is an outstanding challenge to cancer treatment. By taking advantage of recent advances in DNA aptamer biology and mesoporous silica nanotechnology, we report a general approach to design and fabricate controlled release drug delivery systems that are able to effectively target cancer cells. Specifically, polyvalent mesoporous silica nanocarriers-aptamer bioconjugates were constructed; the high-surface-area nanoporous core allowed high drug loading and the surface-conjugated aptamer facilitated the nanoparticle targeting of nucleolin overexpressed MCF-7 cells. The efficient cancer-cell-specific fluorescent imaging and drug delivery of the bioconjugates outline the great potential for therapeutic applications.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据